Banner Location Image
Request Free Consultation
Posted on April 3, 2012

FDA Warns of Cancer-Causing Agent in Japanese Diet Pills

Another consumer warning has been issued by the Food and Drug Administration, this one concerning a type of diet pill that contains a dangerous ingredient. Consumers are being advised to immediately discontinue use of Japan Rapid Weight Loss Diet Pills Green.  This item is available on Amazon and other online retailers.  It is distributed by… read more

Read Article
Posted on April 3, 2012

FDA Addresses Drug Cargo Theft Dangers in New Ruling

The Food and Drug Administration is taking steps to ensure that consumers are safe from drugs that may have been stolen from pharmaceutical companies. It’s an issue that the general public probably isn’t all that aware of, and the FDA aims to change that.  They have instituted new standard operating procedures that pharmaceutical companies are… read more

Read Article
Posted on December 27, 2011

HIV Drug Isentress Gains Expanded FDA Approval

According to news sources, the drug Isentress (raitegravir) has been given expanded approval by The Food and Drug Administration to begin being used by those between 2-18 years of age. The drug was first approved for adult usage back in October 2007 under the agency’s accelerated approval program, which aims to make the introduction of… read more

Read Article
Posted on November 10, 2011

Drug Recalls More Frequent than Ever

According to related news articles, the number of drug recalls is higher and higher every year. Allegedly, the pharmaceutical recalls jumped to 150 in the third quarter of 2010 alone. Details from the FDA Enforcement Reports show that the spike in drug recalls may have something to do with the aggressive activity from FDA authorities… read more

Read Article
Posted on September 21, 2011

New Test Will Detect Heparin Contaminants

Researchers have developed a simple test to determine the safety of heparin, a blood thinner, according to news sources. In 2008, several people died and many more were seriously injured after receiving dosages of heparin that had been altered with oversulfated chondroitin sulfate (OSCS), a synthetic dietary supplement that can be taken to treat osteoarthritis…. read more

Read Article
Posted on September 16, 2011

FDA Halts Production of Supplements Making Unapproved Claims

The FDA has stopped a company from distributing amino acid products that they marketed as treatment for neurotransmitter diseases such as Parkinson’s And Alzheimer’s, according to news sources. West Duluth Distribution subsidiaries CHK Nutrition and NeuroResearch Clinics were found to be selling products making unapproved claims in July 2010. Besides Parkinson’s and Alzheimer’s the products… read more

Read Article
Posted on September 14, 2011

DEA Uses Emergency Authority to Ban “Bath Salts”

Synthetic stimulants which mimic the effects of LSD, cocaine, and MDMA drugs being marketed as bath salts and plant food are being banned by the Drug Enforcement Administration, according to news sources. The DEA plans to use emergency scheduling authority to limit the production of these products, citing them as imminent hazards to the public…. read more

Read Article
Posted on September 8, 2011

Ibuprofen Linked to Early Miscarriage

A study which analyzed women who took ibuprofen early in their pregnancy found that that particular drug use can more than double a woman’s risk of an early miscarriage, according to recent reports. The study, carried out by the University of Montreal in Canada and the Ecole Nationale de la Statistique et de l’Analyse de… read more

Read Article
Posted on September 7, 2011

Study Finds Lower Quality of Offshore Drug Plants

A recent study found that offshore drug manufacturing plants are more likely to suffer quality problems than their U.S. mainland counterparts, report news sources. The study, conducted by researchers at Ohio State University, compared manufacturing plants on the U.S. mainland with plants in Puerto Rico. All plants were owned by U.S. pharmaceutical firms, and researchers… read more

Read Article
Posted on September 6, 2011

FDA Recommends Against Anti Blood Clotting Drug

A negative review from the Food and Drug Administration recommends against Xarelto, an anti blood clotting drug used to prevent strokes in those with atrial fibrillation, according to news sources. Atrial fibrillantion is a heart-rhythm disorder that increases one’s chance of a stroke. According to the staff review of the drug released by Bayer and… read more

Read Article

How Can We Help You?

If you have a legal matter you would like to discuss with an attorney from our firm, please call us at (310) 477-1700 or complete and submit the e-mail form below, and we will get back to you.

  • This field is for validation purposes and should be left unchanged.
  • This field is for validation purposes and should be left unchanged.

*Required Fields